Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07CFJ
|
|||
| Former ID |
DNC007184
|
|||
| Drug Name |
1-propionyl-1H-indole-2,3-dione
|
|||
| Synonyms |
1-Propionyl-1H-indole-2,3-dione; 17529-69-0; 1-propanoyl-2,3-dihydro-1H-indole-2,3-dione; Propionylisatin; Isatin-based compound, 9; AC1LBV75; 1-propanoylindole-2,3-dione; CHEMBL386000; BDBM22789; MolPort-002-488-122; IHNYAHBLLCMRCD-UHFFFAOYSA-N; ZINC3086180; ZX-AN080727; ALBB-029917; AKOS001849000; 1-Propionyl-1H-indole-2,3-dione #; MCULE-1099895518; CCG-139392; 1H-Indole-2,3-dione, 1-(1-oxopropyl)-; EU-0084456; 1H-Isoindole-2,3(2H)-dione, 1-propionyl-; SR-01000512691
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H9NO3
|
|||
| Canonical SMILES |
CCC(=O)N1C2=CC=CC=C2C(=O)C1=O
|
|||
| InChI |
1S/C11H9NO3/c1-2-9(13)12-8-6-4-3-5-7(8)10(14)11(12)15/h3-6H,2H2,1H3
|
|||
| InChIKey |
IHNYAHBLLCMRCD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Liver carboxylesterase (CES1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Drug metabolism - other enzymes | |||
| Metabolic pathways | ||||
| Pathway Interaction Database | E2F transcription factor network | |||
| WikiPathways | NRF2 pathway | |||
| Nuclear Receptors Meta-Pathway | ||||
| Heroin metabolism | ||||
| Irinotecan Pathway | ||||
| Fluoropyrimidine Activity | ||||
| Phase I biotransformations, non P450 | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Selective inhibition of carboxylesterases by isatins, indole-2,3-diones. J Med Chem. 2007 Apr 19;50(8):1876-85. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.